PSOAX
Price
$30.16
Change
-$0.12 (-0.40%)
Updated
Sep 15 closing price
Net Assets
1.24B
SSGSX
Price
$51.39
Change
-$0.14 (-0.27%)
Updated
Sep 15 closing price
Net Assets
4.08B
Interact to see
Advertisement

PSOAX vs SSGSX

PSOAX vs SSGSX Comparison Chart in %
View a ticker or compare two or three
VS
PSOAX vs. SSGSX commentary
Sep 17, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSOAX is a Hold and SSGSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SSGSX has more cash in the bank: 4.08B vs. PSOAX (1.24B). SSGSX pays higher dividends than PSOAX: SSGSX (0.52) vs PSOAX (0.49). PSOAX was incepted earlier than SSGSX: PSOAX (32 years) vs SSGSX (27 years). PSOAX (1.28) and SSGSX (1.23) have similar cost to investors . PSOAX is a more actively managed with annual turnover of: 72.00 vs. SSGSX (50.00). SSGSX initial investment is less costly to investors than PSOAX (5%) vs PSOAX (5%). PSOAX has a lower initial minimum investment than SSGSX: PSOAX (1000) vs SSGSX (2500). PSOAX annual gain was more profitable for investors over the last year : 16.11 vs. SSGSX (10.24). PSOAX return over 5 years is better than : 0.23 vs. SSGSX (-2.65).
PSOAXSSGSXPSOAX / SSGSX
Total Expense Ratio1.191.2397%
Annual Report Gross Expense Ratio1.281.23104%
Fund Existence32 years27 years-
Gain YTD20.44915.305134%
Front Load5%6%91%
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets1.24B4.08B30%
Annual Yield % from dividends0.490.5294%
Returns for 1 year16.1110.24157%
Returns for 3 years39.9712.08331%
Returns for 5 years0.23-2.65-9%
Returns for 10 years25.7034.9474%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VHCOX113.84N/A
N/A
Vanguard Capital Opportunity Inv
MGHRX71.42N/A
N/A
Morgan Stanley Inst Growth IR
HIEMX7.63N/A
N/A
Virtus SGA Emerging Markets Equity I
CPOAX46.72N/A
N/A
Morgan Stanley Insight A
KMVAX37.04N/A
N/A
Kirr Marbach Partners Value